KIR down-regulation on NK cells is associated with down-regulation of activating receptors and NK cell inactivation

European Journal of Immunology

Volumn 31, Issue 6, 2001, Pages 1728-1735

  Huard, Bertrand ^a,b   Karlsson, Lars ^a   Triebel, Frédéric ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

Anergy; Major histocompatibility complex; NK cells

Indexed keywords

CD16 ANTIGEN; CD2 ANTIGEN; CELL RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL KINETICS; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; CYTOLYSIS; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; T LYMPHOCYTE; TARGET CELL;

ANIMALS; CELL LINE, TRANSFORMED; CELL MEMBRANE; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; MICE; RECEPTORS, IMMUNOLOGIC;

EID: 0034964948     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200106)31:6<1728::AID-IMMU1728>3.0.CO;2-J     Document Type: Article

References (37)

1. Natural killer cells: From no receptors to too many
2. HLA class I specific inhibitory receptors
3. Human NK cells: Their ligands, receptors and functions
4. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor
5. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells
6. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
7. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis
8. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
9. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
10. Early signaling via inhibitory and activating NK receptors
11. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells
12. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions
13. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells
14. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells
15. + T cells is controlled by T cell receptor engagement
16. Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity
17. Target-induced anergy of natural killer cytotoxic function is restricted to the NK-target conjugate subset
18. Target-induced inactivation and cell death by apoptosis in a subset of human NK cells
19. Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans
20. CD69-mediated pathway of lymphocyte activation: Anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta
21. Activating interactions in human NK cell recognition: The role of 2B4- CD48
22. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase
23. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes
24. A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing
25. Evidence for protein tyrosine kinase involvement in ligand-induced TCR/CD3 internalization and surface redistribution
26. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors
27. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors
28. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E
29. Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties
30. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells
31. Inhibitory receptors alter natural killer cell interactions with target cells yet allow simultaneous killing of susceptible targets
32. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses
33. Natural history of HLA expression during tumour development
34. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line
35. Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function
36. CD3.TCR1, a human CD3 epitope expressed on viable gamma/delta lymphocytes exclusively
37. CD4/major histocompatibility complex class II interaction analyzed with CD4- and lymphocyte activation gene-3 (LAG-3)-Ig fusion proteins